Supriya Lifescience Limited Statistics
Want to see IN:SUPRIYA full AI Analyst Report?
Supriya Lifescience Limited (SUPRIYA) Stock Statistics & Valuation Metrics
Total Valuation
Supriya Lifescience Limited has a market cap or net worth of INR 49.48B. The enterprise value is INR 75.83B.
- Market Cap
- INR 49.48B
- Enterprise Value
- INR 75.83B
Share Statistics
Supriya Lifescience Limited has 80,482,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 80,482,800
- Owned by Insiders
- ―
- Owned by Institutions
- 0.48%
Financial Efficiency
Supriya Lifescience Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 16.35%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- 0.15
- Return on Invested Capital (ROIC)
- 16.35%
- Return on Capital Employed (ROCE)
- 0.21
- Revenue Per Employee
- 13.64M
- Profits Per Employee
- 3.45M
- Employee Count
- 607
- Asset Turnover
- 0.61
- Inventory Turnover
- 2.38
Valuation Ratios
The current PE Ratio of Supriya Lifescience Limited is 27.93. Supriya Lifescience Limited’s PEG ratio is -9.59.
- PE Ratio
- 27.93
- PS Ratio
- 5.61
- PB Ratio
- 3.99
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -9.59
Income Statement
In the last 12 months, Supriya Lifescience Limited had revenue of 8.28B and earned 2.09B in profits. Earnings per share was 25.98.
- Revenue
- 8.28B
- Gross Profit
- 4.49B
- Operating Income
- 2.66B
- Pretax Income
- 2.75B
- Net Income
- 2.09B
- EBITDA
- 3.05B
- Earnings Per Share (EPS)
- 25.98
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Supriya Lifescience Limited pays an annual dividend of INR 1.00, resulting in a dividend yield of 0.16%
- Dividend Per Share
- INR 1.00
- Dividend Yield
- 0.16%
- Payout Ratio
- 4.85%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 3.58%
Stock Price Statistics
- Beta
- 0.71
- 52-Week Price Change
- -23.46%
- 50-Day Moving Average
- 858.79
- 200-Day Moving Average
- 787.15
- Relative Strength Index (RSI)
- 23.54
- Average Volume (3m)
- 20.60K
Important Dates
Supriya Lifescience Limited upcoming earnings date is Feb 16, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Feb 16, 2027
- Ex-Dividend Date
- Sep 04, 2025
Financial Position
Supriya Lifescience Limited as a current ratio of 4.40, with Debt / Equity ratio of 0.45%
- Current Ratio
- 4.40
- Quick Ratio
- 3.08
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.11
- Interest Coverage Ratio
- 140.62
Taxes
In the past 12 months, Supriya Lifescience Limited has paid 656.59M in taxes.
- Income Tax
- 656.59M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Supriya Lifescience Limited EV to EBITDA ratio is 17.86, with an EV/FCF ratio of 0.00.
- EV to Sales
- 5.53
- EV to EBITDA
- 17.86
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Supriya Lifescience Limited has INR 759.31M in cash and marketable securities with INR 58.03M in debt, giving a net cash position of INR 701.28M billion.
- Cash & Marketable Securities
- INR 759.31M
- Total Debt
- INR 58.03M
- Net Cash
- INR 701.28M
- Net Cash Per Share
- INR 8.71
- Tangible Book Value Per Share
- INR 154.06
Margins
Gross margin is 62.88%, with operating margin of 33.78%, and net profit margin of 20.10%.
- Gross Margin
- 62.88%
- Operating Margin
- 33.78%
- Pretax Margin
- 26.95%
- Net Profit Margin
- 20.10%
- EBITDA Margin
- 30.98%
- EBIT Margin
- 27.15%
Analyst Forecast
The average price target for Supriya Lifescience Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 23.00%
- EPS Growth Forecast
- -2.84%
Scores
- Smart Score
- ―
- AI Score
- 62

